Consumers Increasingly Opting For Microarrays
Microarrays have revolutionized the scientific world from their initial applications to uncover gene expression patterns to diagnostics and prognostics of various medical aids to then understanding the interplay between immune responses and disease.
On technology trends
Microarray technology is one of most recent advances being used for research in infectious disease diagnosis, in diagnosis of allergy, autoimmune disorders, gene expression, and DNA sequencing. Fusion of ELISA and microarray technology has recently showed its application in diagnosing IgG antibodies raised against specific foods commonly called as food intolerance/sensitivity – a condition that is often misdiagnosed as allergy.
On key growth drivers
In the microarray technique multiple analytes are impregnated into a small area of micro-chip. This technology reduces the restrictions in terms of sample volume, time of analysis, and other resources. Microarray technology has been hybridized with high sensitivity and specificity thereby allowing precise detection of their intended targets.
On buyer’s perspective
There is an ongoing trend that customers are opting for microarray systems; in the long term, the running cost of microarray systems would prove to be significantly lower than that of closed systems. Although microarray technology is still in its infancy, further investigation may prove helpful in the preventive diagnosis, prognosis, and management of various diagnostics approaches toward wellness or wellbeing.
On challenges and opportunities
The potential medical applications of microarrays have generated much excitement, and some skepticism, within the biomedical community. Since, the market for microarray system is at a nascent stage, the usage is very limited. Some buyers believe that within a decade, microarrays will be routinely used in the selection, assessment, and quality control for pharmaceutical development, as well as for disease and preventive diagnosis and for monitoring desired/adverse outcomes of therapeutic interventions. Once the requirements of clinicians and researchers regarding affordability and profitability are met, the adaptability of the technology will increase.
Outlook
The usage of microarray throughout the country may evolve rapidly once the technology becomes affordable. There could be scope of development of microarray over autoimmunity, allergy, and other infectious disease. This could result in better accuracy and patient profiling to offer précised and rapid initiation of therapy for faster recovery.
